Vikas T. Talreja

Kanpur, UP, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East.

Social media for healthcare professionals in oncology: results from a cross-sectional survey conducted across eight countries in Asia, Latin America, and the Middle East.

Journal: Future oncology (London, England)

Published: September 12, 2025

Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC).

Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC).

Journal: South Asian journal of cancer

Published: March 24, 2025

Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study.

Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study.

Journal: South Asian journal of cancer

Published: March 03, 2025

Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.

Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomes.

Journal: Cancer letters

Published: January 16, 2025

A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer.

A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: March 11, 2024

Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings.

Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings.

Journal: South Asian journal of cancer

Published: August 01, 2023

Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study.

Treatment pattern and outcomes of leptomeningeal carcinomatosis in India - a retrospective study.

Journal: The Lancet regional health. Southeast Asia

Published: July 07, 2022

Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety.

Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety.

Journal: Indian journal of cancer

Published: March 28, 2022

Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.

Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.

Journal: Oral oncology

Published: March 11, 2022

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience.

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience.

Journal: South Asian journal of cancer

Published: August 16, 2021

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study.

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation-a phase 3 study.

Journal: Ecancermedicalscience

Published: April 11, 2021

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings.

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings.

Journal: Ecancermedicalscience

Published: February 02, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026